Epicardial and subcutenious adipose tissue adiponectin gene expression in coronary artery disease patients

Aim To determine the expression of adiponectin gene (ADIPOQ) and the content of high-molecular-weight adiponectin (HMWA) in epicardial (EAT) and subcutaneous adipose tissue (SCAT) in patients with ischemic heart disease (IHD).
Material and methods Paired samples of EAT and SCAT and blood serum were withdrawn from patients with IHD after bypass surgery and 16 subjects without IHD (comparison group). Matrix RNA (mRNA) level was measured using real-time polymerase chain reaction. HMWA levels in EAT and SCAT were evaluated by Western blotting. Serum adiponectin concentration was measured immunoenzymatically. For all patients, echocardiography was performed to measure the EAT thickness; coronarography was performed to determine severity of coronary atherosclerosis.
Results Serum adiponectin concentration was lower in IHD patients than in the comparison group (p<0.001). Levels of ADIPOO gene mRNA and HMWA in SCAT were lower in IHD patients than in the comparison group (р=0.020 and p=0.003, respectively). The HMWA level in EAT was lower with the EAT thickness of 8 mm compared to the HMWA level in IHD patients with EAT ≤8 mm (p=0.034).
Conclusion The decreased serum concentration of antiatherogenic adiponectin and the reduced expression of ADIPOQ gene in SCAT (mRNA, HMWA) are associated with IHD.

1. W-hite U, Ravussin E. Dynamics of adipose tissue turnover in human metabolic health and disease. Diabetologia. 2019;62(1):17–23. DOI: 10.1007/s00125-018-4732-x

2. Iacobellis G. Epicardial fat: a new cardiovascular therapeutic target. Current Opinion in Pharmacology. 2016;27:13–8. DOI: 10.1016/j.coph.2016.01.004

3. Iwasaki K, Urabe N, Kitagawa A, Nagao T. The association of epicardial fat volume with coronary characteristics and clinical outcome. The International Journal of Cardiovascular Imaging. 2018;34(2):301–9. DOI: 10.1007/s10554-017-1227-7

4. Nagy E, Jermendy AL, Merkely B, Maurovich-Horvat P. Clinical importance of epicardial adipose tissue. Archives of Medical Science. 2017;13(4):864–74. DOI: 10.5114/aoms.2016.63259

5. Chistiakov DA, Grechko AV, Myasoedova VA, Melnichenko AA, Orekhov AN. Impact of the cardiovascular system-associated adipose tissue on atherosclerotic pathology. Atherosclerosis. 2017;263:361–8. DOI: 10.1016/j.atherosclerosis.2017.06.017

6. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nature Clinical Practice Cardiovascular Medicine. 2005;2(10):536–43. DOI: 10.1038/ncpcardio0319

7. Gaborit B, Sengenes C, Ancel P, Jacquier A, Dutour A. Role of Epicardial Adipose Tissue in Health and Disease: A Matter of Fat? Comprehensive Physiology. 2017;7(3):1051–82. DOI: 10.1002/cphy.c160034

8. Douglass E, Greif S, Frishman WH. Epicardial Fat: Pathophysiology and Clinical Significance. Cardiology in Review. 2017;25(5):230–5. DOI: 10.1097/CRD.0000000000000153

9. Karbowska J, Kochan Z. Role of adiponectin in the regulation of carbohydrate and lipid metabolism. Journal of Physiology and Pharmaco­logy. 2006;57(Suppl 6):103–13. PMID: 17228091

10. Villarreal-Molina MT, Antuna-Puente B. Adiponectin: Anti-inflammatory and cardioprotective effects. Biochimie. 2012;94(10):2143–9. DOI: 10.1016/j.biochi.2012.06.030

11. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology. 2002;13(1):134–41. PMID: 11752030

12. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M et al. Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation. 2002;106(22):2767–70. DOI: 10.1161/01.CIR.0000042707.50032.19

13. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA. 2009;302(2):179–88. DOI: 10.1001/jama.2009.976

14. Rutkowski JM, Scherer PE. Isolation and Quantitation of Adiponectin Higher Order Complexes. Methods in Enzymology. 2014;537:243–59. DOI: 10.1016/B978-0-12-411619-1.00013-6

15. Belyaeva O.D., Brovin D.L., Berezina A.V., Karonova T.L., Chubenko E.A., Berkovich O.A., et al. Total and high-molecular weight adiponectin level in hypertensive women with abdominal obesity. Arterial Hypertension. 2014;20(5):442–9. [Russian: Беляева О.Д., Бровин Д.Л., Березина А.В., Каронова Т.Л., Чубенко Е.А., Беркович О.А. и др. Уровень общего и высокомолекулярного адипонектина у женщин с абдоминальным ожирением и артериальной гипертензией. Артериальная гипертензия. 2014;20(5):442-9]

16. Pischon T, Hu FB, Girman CJ, Rifai N, Manson JE, Rexrode KM et al. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis. 2011;219(1):322–9. DOI: 10.1016/j.atherosclerosis.2011.07.011

17. Du Y, Ji Q, Cai L, Huang F, Lai Y, Liu Y et al. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovascular Diabetology. 2016;15(1):90. DOI: 10.1186/s12933-016-0406-5

18. Gormez S, Demirkan A, Atalar F, Caynak B, Erdim R, Sozer V et al. Adipose Tissue Gene Expression of Adiponectin, Tumor Necrosis Factor-α and Leptin in Metabolic Syndrome Patients with Coronary Artery Disease. Internal Medicine. 2011;50(8):805–10. DOI: 10.2169/internalmedicine.50.4753

19. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29(6):251–5. DOI: 10.1016/j.cyto.2004.11.002

20. Norlén A, Alvén J, Molnar D, Enqvist O, Norrlund RR, Brandberg J et al. Automatic pericardium segmentation and quantification of epicardial fat from computed tomography angiography. Journal of Medical Imaging. 2016;3(3):034003. DOI: 10.1117/1.JMI.3.3.034003

21. Kuznetsova T.Yu., Chumakova G.A., Druzhilov M.A., Veselovskaya N.G. Clinical application of quantitative echocardiography assessment of epicardial fat tissue in obesity. Russian Journal of Cardiology. 2017;22(4):81–7. [Russian: Кузнецова Т.Ю., Чумакова Г.А., Дружилов М.А., Веселовская Н.Г. Роль количественной эхокардиографической оценки эпикардиальной жировой ткани у пациентов с ожирением в клинической практике. Российский кардиологический журнал. 2017;22(4):81-7]. DOI: 10.15829/1560-4071-2017-4-81-87

22. Bokeria L. A., Aronov D. M. Russian clinical guidelines Coronary artery bypass grafting in patients with ischemic heart disease: rehabilitation and secondary prevention. CardioSomatics. 2016;7(3–4):5–71. [Russian: Бокерия Л. А., Аронов Д. М. Российские клинические рекомендации. Коронарное шунтирование больных ишемической болезнью сердца: реабилитация и вторичная профилактика. CardioСоматика. 2016;7(3-4):5-71]

23. Montalescot G, Sechtem W, Achenbach S, Andreotti F, Arden C, Budaj A et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;34(38):2949–3003. DOI: 10.1093/eurheartj/eht296

24. Miroshnikova V.V., Panteleeva A.A., Bazhenova E.A., Demina E.P., Usenko T.S., Nikolaev M.A. et al. Regulation of ABCA1 and ABCG1 gene expression in the intraabdominal adipose tissue. Biomedical Chemistry. 2016;62 (3):283–9. [Russian: Мирошникова В. В., Пантелеева А. А., Баженова Е. А., Демина Е. П., Усенко Т. С., Николаев М. А. и др. Регуляция экспрессии генов транспортеров ABCA1 и ABCG1 в интраабдоминальной жировой ткани. Биомедицинская химия. 2016;62(3):283-9]. DOI: 10.18097/PBMC20166203283

25. Ogorodnikova AD, Wassertheil-Smoller S, Mancuso P, Sowers MR, Rajpathak SN, Allison MA et al. High-Molecular-Weight Adiponectin and Incident Ischemic Stroke in Postmenopausal Women: A Women’s Health Initiative Study. Stroke. 2010;41(7):1376–81. DOI: 10.1161/STROKEAHA.109.576546

26. Brovin D.L., Belyaeva O.D., Pchelina S.N., Berezina A.V., Karonova T.L., Bazhenova E.A. et al. Common Carotid Intima–Media Thickness, Levels of Total and High-Molecular Weight Adiponectin in Women with Abdominal Obesity. Kardiologiia. 2018;58(6):29–36. [Russian: Бровин Д.Л., Беляева О.Д., Пчелина С.Н., Березина А.В., Каронова Т.Л., Баженова Е.А. и др. Толщина комплекса интима-медиа общих сонных артерий, уровень общего и высокомолекулярного адипонектина у женщин с абдоминальным ожирением. Кардиология. 2018;58(6):29-36]. DOI: 10.18087/cardio.2018.6.10122

27. Kizer JR, Benkeser D, Arnold AM, Djousse L, Zieman SJ, Mukamal KJ et al. Total and High-Molecular-Weight Adiponectin and Risk of Coronary Heart Disease and Ischemic Stroke in Older Adults. The Journal of Clinical Endocrinology & Metabolism. 2013;98(1):255–63. DOI: 10.1210/jc.2012-2103

28. Jonas MI, Kurylowicz A, Bartoszewicz Z, Lisik W, Jonas M, Domienik-Karlowicz J et al. Adiponectin/resistin interplay in serum and in adipose tissue of obese and normal-weight individuals. Diabetology & Metabolic Syndrome. 2017;9(1):95. DOI: 10.1186/s13098-017-0293-2

29. Sadashiv, Tiwari S, Paul BN, Kumar S, Chandra A, Dhananjai S et al. Adiponectin mRNA in adipose tissue and its association with metabolic risk factors in postmenopausal obese women. Hormones. 2013;12(1):119–27. DOI: 10.1007/BF03401293

30. Razgildina N.D., Brovin D.L., Pobozheva I.A., Panteleeva A.A., Miroshnikova V.V., Belyaeva O.D. et al. Adiponectine gene expression in subcutaneous and intra-abdominal adipose tissue in women with varying degrees of obesity. Tsitologiya. 2018;60(7):531–5. [Russian: Разгильдина Н.Д., Бровин Д.Л., Побожева И.А., Пантелеева А.А., Мирошникова В.В., Беляева О.Д. и др. Экспрессия гена ADIPOQ в подкожной и интраабдоминальной жировой ткани у женщин с различной степенью ожирения. Цитология. 2018;60(7):531-5]. DOI: 10.31116/tsitol.2018.07.08

31. Bambace C, Sepe A, Zoico E, Telesca M, Olioso D, Venturi S et al. Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes. Heart and Vessels. 2014;29(1):42–8. DOI: 10.1007/s00380-012-0315-9

32. Eiras S, Teijeira-Fernández E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzalez-Juanatey JR. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine. 2008;43(2):174–80. DOI: 10.1016/j.cyto.2008.05.006

33. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Molecular and Cellular Endocrinology. 2004;219(1–2):9–15. DOI: 10.1016/j.mce.2004.03.002

34. Iacobellis G, Tiziana di Gioia C, Cotesta D, Petramala L, Travaglini C, De Santis V et al. Epicardial Adipose Tissue Adiponectin Expression is Related to Intracoronary Adiponectin Levels. Hormone and Metabolic Research. 2009;41(03):227–31. DOI: 10.1055/s-0028-1100412

35. Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circulation Research. 2016;118(11):1786–807. DOI: 10.1161/CIRCRESAHA.115.306885

36. Tachibana M, Miyoshi T, Osawa K, Toh N, Oe H, Nakamura K et al. Measurement of epicardial fat thickness by transthoracic echocardiography for predicting high-risk coronary artery plaques. Heart and Vessels. 2016;31(11):1758–66. DOI: 10.1007/s00380-016-0802-5

37. Fuller B, Garland J, Anne S, Beh R, McNevin D, Tse R. Increased Epicardial Fat Thickness in Sudden Death From Stable Coronary Artery Atherosclerosis: The American Journal of Forensic Medicine and Pathology. 2017;38(2):162–6. DOI: 10.1097/PAF.0000000000000310

38. Ansari MA, Mohebati M, Poursadegh F, Foroughian M, Sepehri Shamloo A. Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease? A systematic review and meta-analysis. Electronic Physician. 2018;10(9):7249–58. DOI: 10.19082/7249

39. Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases. 2009;19(3):211–7. DOI: 10.1016/j.numecd.2008.05.002

40. Chu C-Y, Lee W-H, Hsu P-C, Lee M-K, Lee H-H, Chiu C-A et al. Association of Increased Epicardial Adipose Tissue Thickness with Adverse Cardiovascular Outcomes in Patients with Atrial Fibrillation: Medicine. 2016;95(11):e2874. DOI: 10.1097/MD.0000000000002874

41. Lu C, Jia H, Wang Z. Association between epicardial adipose tissue and adverse outcomes in coronary heart disease patients with percutaneous coronary intervention. Bioscience Reports. 2019;39(5):BSR20182278. DOI: 10.1042/BSR20182278

42. Sade LE, Eroglu S, Bozbaş H, Özbiçer S, Hayran M, Haberal A et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis. 2009;204(2):580–5. DOI: 10.1016/j.atherosclerosis.2008.09.038

43. Liu M, Liu F. Regulation of adiponectin multimerization, signaling and function. Best Practice & Research Clinical Endocrinology & Metabolism. 2014;28(1):25–31. DOI: 10.1016/j.beem.2013.06.003

44. Toczylowski K, Hirnle T, Harasiuk D, Zabielski P, Lewczuk A, Dmitruk I et al. Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern. Journal of Translational Medicine. 2019;17(1):310. DOI: 10.1186/s12967-019-2060-7